BRANFORD, Conn., Jan. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation today announced that Company executives will be holding a conference call to discuss CuraGen and 454 Life Sciences’ fourth quarter and year end 2005 financial results at 5:00 p.m. Eastern Time on Thursday, February 2, 2006. A press release outlining 2005 results and year 2006 financial guidance for CuraGen and 454 Life Sciences will be issued prior to the call.
Date: Thursday, February 2, 2006 Time: 5:00 p.m. ET Dial-in: 877-272-5391 (domestic) 706-758-4315 (international) Passcode: 4597920 Webcast: Access to the live webcast is available on CCBN and at http://www.curagen.com.
A replay of the conference call will be available starting at 8:00 p.m. Eastern time on Thursday, February 2, 2006 through Thursday, March 2, 2006 by dialing 800-642-1687 (domestic) or 706-645-9291 (international). The passcode for the replay is 4597920. An archive of the webcast will be available for 30 days at http://www.curagen.com.
About CuraGen
CuraGen Corporation is a biopharmaceutical company dedicated to improving the lives of patients by developing a pipeline of novel protein, antibody, and small molecule therapeutics in the areas of oncology, inflammatory diseases, and diabetes. CuraGen has established broad development alliances with Abgenix, TopoTarget, and Bayer, and its experienced preclinical and clinical teams are advancing the Company’s pipeline of products for unmet medical needs. The Company is headquartered in Branford, CT. For additional information please visit http://www.curagen.com.
CuraGen Contact: Glenn Schulman, Pharm.D. Assistant Director of Investor Relations gschulman@curagen.com (888) 436-6642
CuraGen Corporation
CONTACT: Glenn Schulman, Pharm.D., Assistant Director of InvestorRelations of CuraGen, +1-888-436-6642, gschulman@curagen.com
Web site: http://www.curagen.com//